Kalbe Farma

Kalbe Farma PTKFF Stock

$0.05   0.000000%
Add to favorites
Market Cap
$2.37B
LOW - HIGH [24H]
$0.04 - $0.04
VOLUME [24H]
$10.00K
P/E Ratio
0
Earnings per share
$0.00
ISIN
ID1000125107
Price   Prediction

Kalbe Farma Price Chart

Sorry, that's all we've gotfor now...

Kalbe Farma PTKFF Financial and Trading Overview

Kalbe Farma stock price 0.05 USD
Previous Close 0.05 USD
Open 0.04 USD
Bid 0.04 USD x 3000000
Ask 0.05 USD x 1000000
Day's Range 0.04 - 0.04 USD
52 Week Range 0.04 - 0.08 USD
Volume 10K USD
Avg. Volume 82 USD
Market Cap 2.37B USD
Beta (5Y Monthly) -0.045
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield 0 (2.13%)
Ex-Dividend Date June 4, 2026
1y Target Est N/A

PTKFF Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) 2.92
Price/Sales (ttm) N/A
Price/Book (mrq) 0.000103349994
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Kalbe Farma Stock Price History

Beta (5Y Monthly) -0.045
52-Week Change -16.29%
S&P500 52-Week Change 14.57%
52 Week High 0.08 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.05 USD
200-Day Moving Average 0.06 USD

PTKFF Share Statistics

Avg. Volume (3 month) 82 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 45.25B
Float 17.99B
Short Ratio N/A
% Held by Insiders 64.87%
% Held by Institutions 10.58%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 221.00%
Payout Ratio 0.25190002
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 9.56%
Operating Margin (ttm) 0%
Gross Margin 37.36%
EBITDA Margin 13.37%

Management Effectiveness

Return on Assets (ttm) 9.22%
Return on Equity (ttm) 14.76%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 18.19%
Gross Profit (ttm) N/A
EBITDA 5.04T USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) -0.80%

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 3.21 USD
Current Ratio (mrq) 3.153
Book Value Per Share (mrq) 507.015

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) 1.98T USD

Profile of Kalbe Farma

Country United States
State N/A
City Jakarta
Address Gedung KALBE
ZIP 10510
Phone 62 21 4287 3888
Website https://www.kalbe.co.id
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 12806

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Q&A For Kalbe Farma Stock

What is a current PTKFF stock price?

Kalbe Farma PTKFF stock price today per share is 0.05 USD.

How to purchase Kalbe Farma stock?

You can buy PTKFF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Kalbe Farma?

The stock symbol or ticker of Kalbe Farma is PTKFF.

Which industry does the Kalbe Farma company belong to?

The Kalbe Farma industry is Drug Manufacturers - General.

How many shares does Kalbe Farma have in circulation?

The max supply of Kalbe Farma shares is 45.25B.

What is Kalbe Farma Price to Earnings Ratio (PE Ratio)?

Kalbe Farma PE Ratio is now.

What was Kalbe Farma earnings per share over the trailing 12 months (TTM)?

Kalbe Farma EPS is 0 USD over the trailing 12 months.

Which sector does the Kalbe Farma company belong to?

The Kalbe Farma sector is Healthcare.

$2.74T
Total marketcap
$115.37B
Total volume
BTC 59.16%   •   ETH 10.78%
Dominance
Select currency